论文部分内容阅读
作者将人类免疫缺陷症病毒(HIV)感染母亲所生的51名婴幼儿分为两组,即在接种乙型肝炎疫苗前HIV抗体已转阴的儿童33名(SR组)和HIV感染儿童18例(HIV组)。SR组中17名男性,HIV组中8例男性。乙型肝炎疫苗免疫前,均无乙型肝炎病毒(HBV)感染标志。全部对象均接种重组乙型肝炎疫苗(Smith Kline公司生产),剂量为20μg,第1针后1个月接种第2针,6个月按种第3针。新生儿和1月龄婴儿接种于臀部,较大婴幼儿接种于上臂三角肌,均为肌肉注射。3针免疫后2～4月抗体滴度<10mIU/
The authors categorized 51 infants born to mothers infected with human immunodeficiency virus (HIV) into two groups: 33 (SR group) HIV-negative children and SRV-infected children 18 before vaccination with hepatitis B vaccine Example (HIV group). 17 men in the SR group and 8 men in the HIV group. Hepatitis B virus infection before immunization, no signs of hepatitis B virus (HBV) infection. All subjects were vaccinated with recombinant hepatitis B vaccine (manufactured by Smith Kline) at a dosage of 20 μg. The second needle was administered one month after the first needle and the third needle was planted six months later. Neonates and 1-month-old infants inoculated in the buttocks, infants larger infants in the upper arm deltoid, are intramuscular injection. 3-pin immunization 2 to 4 months after the antibody titer <10mIU /